South Africa says it will stagger the release of the Oxford-AstraZeneca jab after trials showed it gives little protection against the highly contagious local variant.
The vaccine was only minimally effective in preventing mild-to-moderate illness against the dominant South African variant.
South Africa is also looking to other manufacturers such as Pfizer and Johnson & Johnson and the government says it expects to receive these new vaccines in due time.
Al Jazeera’s Fahmida Miller reports from Johannesburg, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#SouthAfrica #COVID19Vaccine #AstraZeneca
The vaccine was only minimally effective in preventing mild-to-moderate illness against the dominant South African variant.
South Africa is also looking to other manufacturers such as Pfizer and Johnson & Johnson and the government says it expects to receive these new vaccines in due time.
Al Jazeera’s Fahmida Miller reports from Johannesburg, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#SouthAfrica #COVID19Vaccine #AstraZeneca
- Category
- World
- Tags
- coronavirus deaths, coronavirus news, south africa coronavirus outbreak
Sign in or sign up to post comments.
Be the first to comment